Open Innovation in Pharma
The Genetic Engineering and Biotechnological News website posted an article which notes that as many big pharmas are maturing they have become more akin to manufacturing organizations with less internal innovation. This is where accessing science from academic centers of excellence and SMEs can help; many pharmas are now altering their business model and will increasingly access innovation in drug discovery from external sources.
Click here to read the full article.